BioLife Solutions

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLFS and other ETFs, options, and stocks.

About BLFS

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services.

CEO

Roderick de Greef

CEORoderick de Greef

Employees

159

Employees159

Headquarters

Bothell, Washington

HeadquartersBothell, Washington

Founded

1987

Founded1987

Employees

159

Employees159

BLFS Key Statistics

Market cap

1.26B

Market cap1.26B

Price-Earnings ratio

-211.82

Price-Earnings ratio-211.82

Dividend yield

—

Dividend yield—

Average volume

747.20K

Average volume747.20K

High today

$26.25

High today$26.25

Low today

$25.17

Low today$25.17

Open price

$25.36

Open price$25.36

Volume

427.45K

Volume427.45K

52 Week high

$29.55

52 Week high$29.55

52 Week low

$19.10

52 Week low$19.10

BLFS News

TipRanks 22h

BioLife Solutions Holds Annual Stockholders Meeting

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Simply Wall St 1d

Does Raised 2025 Revenue Guidance Reinforce the Growth Story for BioLife Solutions?

Earlier this month, BioLife Solutions announced higher full-year 2025 revenue guidance of US$100.0 million to US$103.0 million after reporting second quarter re...

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own BLFS. This list is generated using Robinhood data, and it’s not a recommendation.